Research Topics
| Pieter A CohenSummaryAffiliation: Cambridge Health Alliance Country: USA Publications
| Collaborators |
Detail Information
Publications
A false sense of security? The U.S. Food and Drug Administration's framework for evaluating new supplement ingredientsPieter A Cohen
Harvard Medical School, Boston, Massachusetts, USA
Antioxid Redox Signal 16:458-60. 2012..In the absence of significant modifications, the FDA's guidance may have the effect of providing a false sense of security to consumers seeking safe dietary supplements...
One-on-OnePieter Cohen
Cambridge Health Alliance, Harvard Medical School, Somerville, MA 02143, USA
J Gen Intern Med 22:1480. 2007
Imported compounded diet pill use among Brazilian women immigrants in the United StatesPieter A Cohen
Department of Medicine, Cambridge Health Alliance, Cambridge, MA 02143, USA
J Immigr Minor Health 11:229-36. 2009..To enhance care of Brazilian immigrants, US physicians should become familiar with the health consequences of imported diet pills from Brazil...
Imported fenproporex-based diet pills from Brazil: a report of two casesPieter A Cohen
Department of Internal Medicine, Cambridge Health Alliance, Cambridge, MA, USA
J Gen Intern Med 24:430-3. 2009..Increasing physicians' awareness of imported diet pill use may improve care of patients suffering from the pills' many adverse effects...
Safety of herbal supplements: a guide for cardiologistsPieter A Cohen
Harvard Medical School, Cambridge Health Alliance, Somerville, MA 02143, USA
Cardiovasc Ther 28:246-53. 2010..We review clinically relevant patterns of adverse cardiovascular reactions to herbal supplements, and we provide resources and recommendations for practicing cardiologists evaluating patients with suspected herbal adverse effects...
Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United StatesPieter A Cohen
Department of Medicine, Cambridge Health Alliance, Cambridge, MA 02139, USA
J Gen Intern Med 27:51-6. 2012..The US Food and Drug Administration (FDA) announced a voluntary recall of Pai You Guo in 2009, yet clinicians have noted its continued use among Brazilian-born women in Massachusetts...
